M385T polymorphism in the factor V gene, but not Leiden mutation, is associated with placental abruption in Finnish women

Placenta

Volumn 25, Issue 8-9, 2004, Pages 730-734

  Jaaskelainen E ^a   Toivonen, S ^a   Romppanen, E L ^b   Helisalmi, S ^b   Keski Nisula, L ^a   Punnonen, K ^b   Heinonen, Seppo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; GLUTAMINE; LYSINE; METHIONINE; THREONINE;

ADULT; ARTICLE; CAUCASIAN; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXON; FEMALE; FINLAND; FREQUENCY ANALYSIS; GENE FREQUENCY; GENE MUTATION; GENETIC ALGORITHM; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SOLUTIO PLACENTAE; STATISTICAL SIGNIFICANCE;

ABRUPTIO PLACENTAE; ADULT; FACTOR V; FEMALE; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; POINT MUTATION; POLYMORPHISM, GENETIC; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 4444285503     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2004.02.006     Document Type: Article

References (21)

1. Dahlback B. Hansson C. Islam M.Q. Szpirer J. Szpirer C. Lundwall A. et al. Assignment of gene for coagulation factor V to chromosome 1 in man and to chromosome 13 in rat Somat Cell Mol Genet 14 1988 509-514
2. Kane W.H. Davie E.W. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders Blood 71 1988 539-555
3. Dahlback B. Carlsson M. Svensson P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc Natl Acad Sci U S A 90 1993 1004-1008
4. Bertina R.M. Koeleman B.P. Koster T. Rosendaal F.R. Dirven R.J. de Ronde H. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64-67
5. Zoller B. Svensson P.J. He X. Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C J Clin Invest 94 1994 2521-2524
6. Graf L.L. Welsh C.H. Qamar Z. Marlar R.A. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden Am J Clin Pathol 119 2003 52-60
7. Hiyoshi M. Arnutti P. Prayoonwiwat W. Nathalang O. Suwanasophon C. Kokaseam R. et al. A polymorphism nt 1628G→A (R485K) in exon 10 of the coagulation factor V gene may be a risk factor for thrombosis in the indigenous Thai population Thromb Haemost 80 1998 705-706
8. Le W. Yu J.D. Lu L. Tao R. You B. Cai X. et al. Association of the R485K polymorphism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population Clin Genet 57 2000 296-303
9. Rey E. Kahn S.R. David M. Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis Lancet 361 2003 901-908
10. Spina V. Aleandri V. Morini F. The impact of the factor V Leiden mutation on pregnancy Hum Reprod Update 6 2000 301-306
11. van Pampus M.G. Dekker G.A. Wolf H. Huijgens P.C. Koopman M.M. von Blomberg B.M. et al. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia Am J Obstet Gynecol 180 1999 1146-1150
12. Peltonen L. Jalanko A. Varilo T. Molecular genetics of the Finnish disease heritage Hum Mol Genet 8 1999 1913-1923
13. Faisel F. Romppanen E.L. Hiltunen M. Helisalmi S. Laasanen J. Punnonen K. Heinonen S. Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation Eur J Hum Genet 12 2004 187-191
14. Toivonen S. Heinonen S. Anttila M. Kosma V.M. Saarikoski S. Reproductive risk factors, Doppler findings, and outcome of affected births in placental abruption: a population-based analysis Am J Perinatol 8 2002 451-459
15. Rasmussen S. Irgens L.M. Dalaker K. The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence Br J Obstet Gynaecol 104 1997 1292-1295
16. Yoshimura T. Yoshimura M. Tabata A. Yasue H. Okamura H. The missense Glu298Asp variant of the endothelial nitric oxide synthase gene is strongly associated with placental abruption Hum Genet 108 2001 181-183
17. Wiener-Megnagi Z. Ben-Shlomo I. Goldberg Y. Shalev E. Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae Am J Obstet Gynecol 179 1998 1565-1567
18. Van der Molen E.F. Arends G.E. Nelen W. van der Put N. Heil S.G. Eskes T. et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy Am J Obstet Gynecol 182 2000 1258-1263
19. Pastinen T. Perola M. Ignatius J. Sabatti C. Tainola P. Levander M. et al. Dissecting a population genome for targeted screening of disease mutations Hum Mol Genet 10 2001 2961-2972
20. de Visser M.C. Guasch J.F. Kamphuisen P.W. Vos H.L. Rosendaal F.R. Bertina R.M. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis Thromb Haemost 83 2000 577-582
21. Kupferminc M.J. Eldor A. Steinman N. Many A. Bar-Am A. Jaffa A. et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy N Engl J Med 340 1999 9-13